“These 2 Penny Stocks Could Surge Over 300%, Say Analysts”
January 13, 2021
“AcelRx Pharmaceuticals (ACRX)…
Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, ACRX has a Strong Buy consensus rating. Based on the $7 average price target, shares could soar 407% in the next year…
NuCana (NCNA)…
Overall, NCNA’s Strong Buy consensus rating is unanimous, and based on 4 recent reviews. Shares have an average price target of $17.33, suggesting a 270% one-year upside from the current trading price of $4.69…”
https://finance.yahoo.com/news/2-penny-stocks-could-surge-163948225.html